| LFC | treatment | description | class of inhibitor | 
| 1.609 | Amikacin | ug/mL Amikacin | translation | 
| 1.403 | Cap | 5-10ug/mL Capreomycin | translation | 
| 0.714 | Rox | 10-50 ug/mL Roxithromycin | translation | 
| 0.357 | SM | 2-5 ug/mL Streptomycin | translation | 
| 1.822 | Tet | 5-10 ug/mL Tetracycline | translation | 
| -0.201 | Rif | 0.2-5ug/mL Rifampicin | transcription | 
| -0.422 | Rifp | 0.1-0.5ug/mL Rifapentine | transcription | 
| 0.000 | Min_med__succinate_ | Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerol | starvation | 
| -0.898 | CCCP | 10-50 uM Carbonyl cyanide 3-chlorophenylhydrazone | respiration | 
| -0.207 | CPZ | 10-50 ug/mL Chlorpromazine | respiration | 
| 1.094 | Clofazimine | 10-13 ug/mL Clofazimine | respiration | 
| -0.130 | Clotrimazole | 10-24 ug/mL Clotrimazole (azole drug) | respiration | 
| 0.000 | DCCD | 20-100 uM Dicyclohexylcarbodiimide | respiration | 
| 0.000 | DNP | "0.5-2.5 mM 2,4-Dinitrophenol" | respiration | 
| -0.263 | DTT | "1-2 mM 1,4-Dithio-DL-threitol" | respiration | 
| -0.549 | Econazole | 10-24 ug/mL Econazole (azole drug) | respiration | 
| 0.000 | GSNO_CFZ | 0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofazimine | respiration | 
| -1.121 | GSNO_CPZ | 0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazine | respiration | 
| 0.207 | GSNO_KCN | 0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyanide | respiration | 
| -0.747 | GSNO_menadione | 0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadione | respiration | 
| 0.000 | KCN | 5-20 ug/mL Potassium cyanide | respiration | 
| 0.000 | NaN3 | 0.2-2 mM Sodium azide | respiration | 
| -0.590 | Nigericin | 50 uM Nigericin | respiration | 
| -0.131 | TRC | 10-150 ug/mL Triclosan | respiration | 
| 0.000 | TRZ | 10-25 ug/mL Thioridazine | respiration | 
| 4.293 | Valinomycin | 0.5-10 uM Valinomycin | respiration | 
| 0.000 | ZnSO4 | 2 mM ZnSO4 | respiration | 
| -0.938 | menadione | 6-10 ug/mL Menadione | respiration | 
| 0.073 | Ascididemin_Nat_prod | 4-9 ug/mL Organic extract of Eudistoma amplum | ironLimitation | 
| -0.349 | Deferoxamine | 150-250 uM Deferoxamine mesylate | ironLimitation | 
| -0.276 | Dipyridyl | "100-200 uM 2,2'-Bipyridyl" | ironLimitation | 
| -0.514 | GSNO | 0.02-0.1mM S-Nitrosoglutathione | dosRassociated | 
| -0.356 | NRP_1 | Non-replicating persistence stage 1 | dosRassociated | 
| -0.389 | Amp | 0.2mg/mL Ampicillin | cellWall | 
| -0.181 | Cephalexin | 20-100 ug/mL Cephalexin | cellWall | 
| -0.060 | Cerulenin | 0.32-5 ug/mL Cerulenin | cellWall | 
| -0.195 | DIPED | 5-100 ug/mL Diisopropylethylenediamine | cellWall | 
| -0.013 | EMB | 10-20 ug/mL Ethambutol | cellWall | 
| -0.201 | Eta | 12-40 ug/mL Ethionamide | cellWall | 
| -0.198 | INH | 0.2-0.4 ug/mL Isoniazid | cellWall | 
| 0.036 | TLM | 0.1-0.2 mg/mL Thiolactomycin | cellWall | 
| 0.000 | Palmitate | Minimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole Csource | carbonSource | 
| 0.067 | Succinate | Minimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole Csource | carbonSource | 
| 0.085 | BZA | 0.12 mg/mL Benzamide | aromaticAmides | 
| -0.405 | Nam | 0.12 - 1.2 mg/mL Nicotinamide | aromaticAmides | 
| 0.176 | PZA | 0.12-1.2 mg/mL Pyrazinamide | aromaticAmides | 
| -0.000 | H2O2 | 4 mM hydrogen peroxide | DNAdamaging | 
| -0.292 | Levo | 10 ug/mL Levofloxacin | DNAdamaging | 
| -0.462 | Mtm | 0.1-0.2 ug/mL Mitomycin C | DNAdamaging | 
| 0.868 | Novobiocin | 10 ug/mL Novobiocin | DNAdamaging | 
| -0.107 | Oflox | 5-10 ug/mL Ofloxacin | DNAdamaging | 
| -0.719 | UV | UV-irradiation | DNAdamaging | 
| 0.000 | ARP4 | 1-4 ug/mL Antitubercular compound ARP4 | ? | 
| 0.069 | Antimycin | 12.5-50 ug/mL Antimycin A | ? | 
| -0.818 | DTNB | "1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)" | ? | 
| -0.329 | PA_1 | 10-50 ug/mL Antitubercular compound PA-1 | ? | 
| -0.088 | PA_21 | 10-50 ug/mL Antitubercular compound PA-21 | ? | 
| 0.189 | PA824 | 0.2-2 ug/mL PA-824 | ? | 
| 0.654 | Procept_6776 | 20-30 ug/mL Antitubercular compound Procept 6776 | ? | 
| 0.398 | Procept_6778 | 5-40 ug/mL Antitubercular compound Procept 6778 | ? | 
| -0.675 | Verapamil | 50 uM Verapamil | ? | 
| -0.691 | mercaptoethanol | 2 mM 2-Mercaptoethanol | ? | 
| 0.264 | methoxatin | 10-20 ug/mL Methoxatin | ? |